RxDoctor Payments Data

Shelley Schuler

Physician Assistant · Louisville, KYNPI 1861653214

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $9,590 of the $12,083 with a category attached, or 79.4%. It is spread thinly across 25 manufacturers, the largest accounting for just 19.7% — the pattern of someone who eats at a lot of different presentations. Among physician assistant clinicians in KY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$12,083in general payments, 2019–2025

Across 477 payments — averaging $25.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • UCB, Inc.$2K
  • Sanofi$1K
  • Lilly USA, LLC$765
  • Johnson & Johnson$741
  • Novartis$631
  • plus $4K from 19 others

What the payments were for

  • Consulting fees$1,90016%
  • Food & beverage$9,59079%
  • Education$5925%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$12,083 in reported general payments places this provider in the 95th percentile of 1,448 physician assistant providers in Kentucky.

See all physician assistant providers in Kentucky

Medicare billing

Part B allowed, 2024
$97,708
Medicare patients
413
Services billed
1,628

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab31$114,534
OtezlaApremilast14$64,484
Clobetasol Propionate120$4,667
Calcipotriene12$2,537
Clindamycin Phosphate48$1,483
Doxycycline Monohydrate47$1,459
Ketoconazole126$1,317
Fluorouracil13$1,251
Betamethasone Dipropionate29$1,249
Triamcinolone Acetonide95$1,146
Fluocinonide27$1,142
ValacyclovirValacyclovir Hcl15$907
Metronidazole12$724
Ciclopirox20$508
Nystatin37$461

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AmgenOtezla$273$64,48414 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,448 physician assistant providers in Kentucky.

Other physician assistant in Louisville

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →